Sweet and blind spots in E3 ligase ligand space revealed by a thermophoresis-based assay

December 4, 2020

Maiwald, S., Heim, C., Alvarez, B., et al.

ACS Medicinal Chemistry Letters 2020, doi: 10.1021/acsmedchemlett.0c00440

Abstract

Repurposing E3 ubiquitin ligases for targeted protein degradation via customized molecular glues or proteolysis-targeting chimeras (PROTACs) is an increasingly important therapeutic modality. Currently, a major limitation in the design of suitable molecular glues and PROTACs is our fragmentary understanding of E3 ligases and their ligand space. We here describe a quantitative assay for the discovery and characterization of E3 ligase ligands that is based on the thermophoretic behavior of a custom reporter ligand. Thereby, it is orthogonal to commonly employed fluorescence-based assays and less affected by the optical properties of test compounds. It can be employed for the high-throughput screening of compound libraries for a given ligase but also for hit validation, which we demonstrate with the identification of unexpected well-binders and non-binders, yielding new insights into the ligand space of cereblon (CRBN).

View Publication

Topics: Monolith, MST, PROTACs, Publications

Previous Video
Tackle the high-hanging fruits in challenging drug discovery pipelines
Tackle the high-hanging fruits in challenging drug discovery pipelines

There are a number of interesting drug targets that have a reputation of being especially difficult to stud...

Up next
Tackle undruggable targets by screening for binary and ternary PROTAC interactions using Dianthus
Tackle undruggable targets by screening for binary and ternary PROTAC interactions using Dianthus

Have a question?

Contact Specialist